Process Thousands of HRSA Patients in Minutes with LigoLab
November 19, 2020
Los Angeles, CA, November 19, 2020 - The LigoLab LIS & RCM Operating Platform is fully integrated and features targeted automation that enables users to identify and process thousands of uninsured COVID-19 patients in just minutes. This has proven to be a major advantage for laboratories across the country that have boosted their diagnostic testing capacity to meet the public demand.
The Health Resources & Services Administration (HRSA) program provides claims reimbursement to healthcare providers for the testing of uninsured individuals for COVID-19. The program was first established by the U.S. Department of Health and Human Services (HHS) in February of 2020. For laboratories, this is a time-consuming and labor-intensive process that puts added pressure on their billing departments. For LigoLab users, however, the process is largely automated and can be completed in just a few clicks.
“We’ve automated much of the HRSA reimbursement procedure for our lab partners,” said Farzad Abdi, LigoLab’s Billing Manager. “Our platform automatically initiates insurance discovery service followed by an eligibility check, and if no insurance is found, LigoLab RCM runs a built-in dynamic report that identifies patients without insurance and generates an export file which is uploaded to the HRSA website. Later, a batch file is imported back into LigoLab and the RCM assigns a temporary HRSA ID to the patient encounters automatically.
The alternative is copying and pasting the required patient information into the LIS manually one-by-one, a procedure that’s prone to error.
“With this level of automation, laboratories can handle a much higher capacity for claims without having to expand their billing departments,” continued Abdi, who estimated that more than 10 percent of COVID-19 claims fall into the HRSA reimbursement category. “For high-volume laboratories, this translates into potentially thousands of daily claims that can now be processed in a matter of minutes, rather than taking several hours to complete the task.”
“LigoLab RCM is enhanced by a specialized and customizable rule engine that handles client billing policies automatically,” said Abdi. “The HRSA workflow is just one example. We can build automation to support even the most complicated billing policies, and we can do it in a matter of hours because we have a well-trained and experienced support staff.”
Abdi said LigoLab’s RCM team continues to build out multiple automation rules to help all of its lab partners manage the escalated number of COVID-19 claims. He said it's now possible to largely automate the client billing workflow, and that most insurance claims are being processed without human intervention.
Unite Your LIS & RCM and Truly Revolutionize Your Business
The LigoLab LIS & RCM Operating Platform is a fully integrated information system that connects every laboratory department on one united software infrastructure to transform operations. Unlike traditional RCM solutions, LigoLab starts the revenue cycle process at the order level with powerful verification and scrubbing components that are shared by the LIS and RCM modules. The platform also features automation and a seamless workflow designed to increase operational efficiency, transparency, revenue, and profit.
To learn more about LigoLab's all-in-one platform and its customizable modules for Anatomic Pathology (AP), Clinical Pathology (CP), Molecular Diagnostics (MDx), Revenue Cycle Management (RCM), and Direct-to-Consumer (D2C), call (818) 395-4659 or visit us online at LigoLab.com.
To learn more about LigoLab RCM, contact Michael Kalinowski at 310-227-7503 or michaelk@LigoLab.com.